The information contained in this section of the site is intended for US health care professionals only. Click “OK” if you are a health care professional or specialty pharmacy representative.
The information contained in this section of the site is intended for specialty pharmacy representatives only. Click “OK” if you are a health care professional or specialty pharmacy representative.
The program may be used with one of the following types of health care providers: your doctor's office, infusion center, hospital or specialty pharmacy. Follow the steps below to use the program.
|Tell your health care provider that you are using the Rituxan Immunology Co-pay Program. Provide your health care provider with your Member ID. They can process your co-pay payment by logging into RACopay.com/hcp.|
|After your Rituxan treatment, your health insurance plan will send you an Explanation of Benefits statement, also called an "EOB." They will either send this by mail or email.|
The Rituxan Immunology Co-pay Program needs to see your EOB to confirm your treatment. You or your doctor’s office can send it to us.*
|Your health care provider may use your member information to pay for your costs.† Depending on your health insurance plan’s policies, you may owe additional costs after processing your member information.|
*EOBs must be submitted within 365 days of the date of service.
†This program helps with the drug and infusion costs of Rituxan only. It does not help with the cost of other medicines you take at the same time as Rituxan or with facility fees.
Rituxan is a prescription medicine used to treat:
Adults with Rheumatoid arthritis (RA): with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough.
People with Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA) ages 2 years and above: with glucocorticoids.
Adults with Pemphigus Vulgaris (PV): to treat moderate to severe PV.
Rituxan is not indicated in children less than 2 years of age with GPA or MPA or in children with conditions other than GPA or MPA.
What is the most important information I should know about Rituxan?
Rituxan can cause serious side effects that can lead to death, including:
Before receiving Rituxan, patients should tell their healthcare provider if they:
What are the possible side effects of Rituxan?
Rituxan can cause serious and life-threatening side effects, including:
What are common side effects during treatment with Rituxan?
The most common side effects of Rituxan include:
In patients with GPA or MPA, the most common side effects of Rituxan also include:
Other side effects with Rituxan include:
These are not all of the possible side effects with Rituxan.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.